
Pakistan to Revise Drug Pricing Rules
The Pakistani government has ordered the Drug Regulatory Authority of Pakistan (DRAP) to revise its drug pricing framework. Federal Minister for Economic Affairs and Establishment Division, Senator Ahad Cheema, directed the Ministry of National Health Services and DRAP to urgently review the regulatory framework, including changes to the Hardship Policy and composition of the Policy Board.2 sourcesSee all sources


